Novozymes A/S NVZMY OTC · Basic materials · Denmark
$66.06 -0.22% -$0.15
Summary
39 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 712% this fiscal year.
- Out of every 100 EUR of revenue, 16 EUR is left as free cash.
What to watch
- Revenue fell by 38% a year over the last 3 years.
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- It missed profit estimates 8 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue fell by 22% a year over 5 years. Over the last 3 years it fell by 38% a year. For the next fiscal year analysts expect revenue to grow by 712%. Earnings per share fell by 54% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellOver the last 12 months it made a loss of 203.3M €.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.07%
- Raised in a row
- 1 year
You receive $0.71 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 1
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.